港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

宜明昂科-B

10.820

+1.03010.52%

成交量：630.06万

成交额：6,718.39万

市值：44.07亿

市盈率：-11.83

高：11.160

开：10.100

低：10.000

收：9.790

数据加载中...

总览公司新闻公告

宜明昂科-B04月01日主力净流入675万元散户资金抛售

宜明昂科－Ｂ(01541)股价大幅上升21.918%，现价港币$7.12

阿斯达克财经

港股异动 | 医药股早盘走强国内创新药逐渐进入收获期市场预期集采政策优化

异动解读 | 宜明昂科-B盘中大涨19.52%，年度收入激增192倍

异动解读 | 宜明昂科-B盘中大涨19.52%，年收入暴增192倍

港股异动 | 宜明昂科-B(01541)早盘涨超18% 全年收入同比增长192倍机构称公司目前价值严重低估

宜明昂科-B：核心管线稳步推进积极拓展BD合作

太平洋证券

宜明昂科-B03月27日获主力加仓4万元

港股异动 | 宜明昂科-B(01541)午前涨超3% 年度收入大增至7414.9万元研发开支持续加码

异动解读 | 宜明昂科-B盘中大涨6.17%，董事长增持15万股提振市场信心

宜明昂科(01541.HK)董事长兼CEO增持15万股涉79万元

阿斯达克财经

宜明昂科-B(01541)获首席执行官田文志增持15万股H股

异动解读 | 宜明昂科-B盘中大跌5.17%，年度业绩亏损仍超3亿元

异动解读 | 宜明昂科-B盘中大涨5.17%，2024年营收暴增191倍

宜明昂科2024年业绩：收入增至7414.9万元年内亏损降至3.17亿元

宜明昂科-B(01541)2024年收入大增至7414.9万元研发开支持续加码

宜明昂科-B03月21日主力净流出43万元散户资金买入

宜明昂科-B03月19日主力净流入38万元散户资金抛售

宜明昂科-B03月18日主力净流出52万元散户资金买入

宜明昂科-B(01541.HK)收到H股全流通备案通知书

阿斯达克财经

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/01541/news?page=8"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01541","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","market":"HK","secType":"STK","nameCN":"宜明昂科-B","latestPrice":10.82,"timestamp":1752739688013,"preClose":9.79,"halted":0,"volume":6300600,"delay":0,"floatShares":396277305,"shares":407307695,"eps":-0.9143586557386056,"marketStatus":"已收盘","change":1.03,"latestTime":"07-17 16:08:08","open":10.1,"high":11.16,"low":10,"amount":67183922,"amplitude":0.118488,"askPrice":10.88,"askSize":5000,"bidPrice":10.82,"bidSize":71800,"shortable":0,"etf":0,"ttmEps":-0.9143586557386056,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752802200000},"marketStatusCode":5,"adr":0,"listingDate":1693843200000,"exchange":"SEHK","adjPreClose":9.79,"openAndCloseTimeList":[[1752715800000,1752724800000],[1752728400000,1752739200000]],"volumeRatio":1.47158,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","floatShares":396277305,"roa":"-21.43%","roe":"-44.38%","lyrEps":-0.914359,"volumeRatio":1.47158,"shares":407307695,"dividePrice":0,"high":11.16,"amplitude":0.118488,"preClose":9.79,"low":10,"week52Low":3.21,"pbRate":"5.95","psRate":"50.75","week52High":22,"institutionHeld":0,"latestPrice":10.82,"committee":0.869792,"eps":-0.9143586557386056,"divideRate":0,"volume":6300600,"delay":0,"ttmEps":-0.9143586557386056,"open":10.1,"prevYearClose":5.16,"prevWeekClose":10.2,"prevMonthClose":12,"prevQuarterClose":12,"fiveDayClose":11.5,"twentyDayClose":12.52,"sixtyDayClose":5.05},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01541\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524169399","title":"宜明昂科-B04月01日主力净流入675万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2524169399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524169399?lang=zh_cn&edition=fundamental","pubTime":"2025-04-01 16:15","pubTimestamp":1743495308,"startTime":"0","endTime":"0","summary":"04月01日, 宜明昂科-B股价涨19.86%，报收7.00元，成交金额1.11亿元，换手率4.20%，振幅27.91%，量比4.89。宜明昂科-B今日主力资金（超大单+大单）净流入675万元，上一交易日主力净流出0万元。该股近5个交易日上涨28.23%，主力资金累计净流入691万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入264万元，其中净流入天数为8日。该股主力净额占比0.25%（主力资金净额/流通市值），港股市场排名28/2654。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250401165347a6aba919&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250401165347a6aba919&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2524155062","title":"宜明昂科－Ｂ(01541)股价大幅上升21.918%，现价港币$7.12","url":"https://stock-news.laohu8.com/highlight/detail?id=2524155062","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524155062?lang=zh_cn&edition=fundamental","pubTime":"2025-04-01 14:40","pubTimestamp":1743489600,"startTime":"0","endTime":"0","summary":"[上升股]宜明昂科－Ｂ(01541) 股价在下午02:40比前收市价大幅上升21.918%，现股价为港币$7.12。至目前为止，今日最高价为$7.5，而最低价为$5.87。总成交量为1.388千万股，总成交金额为港币$9.583千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2504013426/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2524056184","title":"港股异动 | 医药股早盘走强 国内创新药逐渐进入收获期 市场预期集采政策优化","url":"https://stock-news.laohu8.com/highlight/detail?id=2524056184","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524056184?lang=zh_cn&edition=fundamental","pubTime":"2025-04-01 10:20","pubTimestamp":1743474025,"startTime":"0","endTime":"0","summary":"消息面上，2025年医保谈判将于二季度拉开帷幕，从今年开始，医保药品目录调整时间会适当提前，预计从4月1日开始申报，争取9月份完成。民生证券表示，中国本土医药创新逐渐进入收获期，国际化进程持续加速，继续重点看好医药创新主线，同时医药板块基本面持续向上复苏，同时看好医药消费主线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1272383.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","09995","LU1969619763.USD","LU0417516571.SGD","IE00B543WZ88.USD","LU1720050803.USD","IE00BPRC5H50.USD","06855","BK1515","09969","LU0348783233.USD","159992","LU2488822045.USD","IE00B5MMRT66.SGD","LU0348784397.USD","BK1574","09926","LU2328871848.SGD","06978","LU1794554557.SGD","01541","159938","09939","BK1583"],"gpt_icon":0},{"id":"1190377977","title":"异动解读 | 宜明昂科-B盘中大涨19.52%，年度收入激增192倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1190377977","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190377977?lang=zh_cn&edition=fundamental","pubTime":"2025-04-01 10:12","pubTimestamp":1743473552,"startTime":"0","endTime":"0","summary":"宜明昂科-B今日盘中股价大涨19.52%，引发市场广泛关注。截至上午10点09分，该股报价6.93港元，成交额达2546.88万港元。此次股价飙升主要源于公司发布的亮眼年度业绩报告。宜明昂科-B全年实现总收入7,415万元，同比增长192倍，收入主要来自授权许可费和合作开发。国元国际分析师对宜明昂科-B给予积极评价。他们指出，基于公司CD47核心产品在肿瘤及自免领域的领先优势和广阔市场空间，目前22亿港元的市值严重低估了公司价值。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01541"],"gpt_icon":0},{"id":"1158405442","title":"异动解读 | 宜明昂科-B盘中大涨19.52%，年收入暴增192倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1158405442","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158405442?lang=zh_cn&edition=fundamental","pubTime":"2025-04-01 10:12","pubTimestamp":1743473549,"startTime":"0","endTime":"0","summary":"宜明昂科-B今日盘中大涨19.52%，引发市场广泛关注。截至发稿时，该股报6.93港元，成交额2546.88万港元。此次股价大涨主要受三方面利好消息推动。国元国际还强调，宜明昂科-B目前市值仅为22亿港元，账上现金有7.4亿人民币，加上潜在的BD收入，公司资金充足，足以支持研发推进。随着公司业绩的持续改善和市场认可度的提升，宜明昂科-B的股价有望继续走强。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01541"],"gpt_icon":0},{"id":"2524066181","title":"港股异动 | 宜明昂科-B(01541)早盘涨超18% 全年收入同比增长192倍 机构称公司目前价值严重低估","url":"https://stock-news.laohu8.com/highlight/detail?id=2524066181","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524066181?lang=zh_cn&edition=fundamental","pubTime":"2025-04-01 10:08","pubTimestamp":1743473295,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，宜明昂科-B早盘涨近18%，截至发稿，涨18.66%，报6.93港元，成交额2546.88万港元。消息面上，宜明昂科发布度业绩，全年实现总收入7,415万元，主要来自授权许可费和合作开发收入，同比增长192倍。此外，宜明昂科-B获首席执行官田文志增持15万股H股，占公司已发行股份总数的约0.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1272368.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"港股异动 | 宜明昂科-B(01541)早盘涨超18% 全年收入同比增长192倍 机构称公司目前价值严重低估","news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2522804574","title":"宜明昂科-B：核心管线稳步推进 积极拓展BD合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2522804574","media":"太平洋证券","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522804574?lang=zh_cn&edition=fundamental","pubTime":"2025-03-28 00:00","pubTimestamp":1743091200,"startTime":"0","endTime":"0","summary":"事件：2025 年3 月25 日，宜明昂科发布2024 年度业绩报告，全年实现总收入7,415 万元，同比增长192 倍。目前两项III 期临床研究均处于稳步推进过程中，预计2026 年进行中期数据分析。两款双特异性抗体积极拓展BD 合作2024 年8 月公司与SynBioTx 签署授权及合作协议，将靶向PDL1/VEGF 的双特异性抗体IMM2510 在大中华地区以外的研究、开发及商业化权益授权给SynBioTx。目前IMM0306 也在积极拓展BD 合作过程中。公司核心管线临床稳步推进，数据读出后估值有望得到修复。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328205845a4456628&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328205845a4456628&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2522779326","title":"宜明昂科-B03月27日获主力加仓4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2522779326","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522779326?lang=zh_cn&edition=fundamental","pubTime":"2025-03-27 16:26","pubTimestamp":1743063984,"startTime":"0","endTime":"0","summary":"03月27日, 宜明昂科-B股价涨5.79%，报收5.66元，成交金额1791万元，换手率0.85%，振幅12.52%，量比1.14。宜明昂科-B今日主力资金净流入4万元，连续3日净流入，上一交易日主力净流入35万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为62.50%，平均涨幅为9.15%。该股近5个交易日上涨16.94%，主力资金累计净流入178万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出643万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250327175731a443ce7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250327175731a443ce7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2522593392","title":"港股异动 | 宜明昂科-B(01541)午前涨超3% 年度收入大增至7414.9万元 研发开支持续加码","url":"https://stock-news.laohu8.com/highlight/detail?id=2522593392","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522593392?lang=zh_cn&edition=fundamental","pubTime":"2025-03-27 11:36","pubTimestamp":1743046618,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，宜明昂科-B午前涨超3%，截至发稿，涨3.36%，报5.53港元，成交额716.89万港元。消息面上，近日，宜明昂科-B公布2024年业绩，收入约7414.9万元，同比增长约191.1倍；研发开支同比增加10.6%至3.23亿元。公司拥有人应占亏损约3.16亿元，同比收窄16.76%；每股亏损0.84元。公告称，收入增长主要归因于根据公司与Axion Bio, Inc.达成的授权及合作协议收取首付款及近期付款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1268737.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"1186123918","title":"异动解读 | 宜明昂科-B盘中大涨6.17%，董事长增持15万股提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1186123918","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186123918?lang=zh_cn&edition=fundamental","pubTime":"2025-03-27 11:12","pubTimestamp":1743045150,"startTime":"0","endTime":"0","summary":"今日盘中，宜明昂科-B股价大涨6.17%，引发市场关注。这一显著涨幅很可能与公司高层近期的增持行为有关。据悉，宜明昂科-B的执行董事、首席执行官兼董事会董事长田文志于昨日（周三）在公开市场增持了15万股公司H股。增持后，田文志持有的公司股份总数达到1.16亿股，占公司已发行股本总额的28.49%。市场普遍认为，作为公司的掌舵人，田文志此次增持反映了其对公司价值的认可和对未来发展的信心，从而带动了股价的上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 宜明昂科-B盘中大涨6.17%，董事长增持15万股提振市场信心","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01541"],"gpt_icon":0},{"id":"2522395418","title":"宜明昂科(01541.HK)董事长兼CEO增持15万股  涉79万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2522395418","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522395418?lang=zh_cn&edition=fundamental","pubTime":"2025-03-27 10:17","pubTimestamp":1743041820,"startTime":"0","endTime":"0","summary":"宜明昂科-B(01541.HK) 公布，执行董事、首席执行官兼董事会董事长田文志于周三(26日)，在公开市场购买合共15万股该公司H股，每股股份平均价格约5.278元，占公司已发行股份总数约0.04%。估算涉约79.17万元。紧随购买后，田文志于合共1.16亿股股份中拥有权益，占于公司已发行股本总额28.49%。(js/da)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-26 16:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230915102623267_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230915102623267_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1428647/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2522138833","title":"宜明昂科-B(01541)获首席执行官田文志增持15万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2522138833","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522138833?lang=zh_cn&edition=fundamental","pubTime":"2025-03-26 22:27","pubTimestamp":1742999234,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B(01541)发布公告，该公司董事会获公司执行董事、首席执行官兼董事会董事长田文志博士告知，其已于2025年3月26日于公开市场购买合共15万股公司H股，每股股份平均价格为约5.278港元，占公司已发行股份总数的约0.04%。紧随购买后，田博士于合共1.16亿股股份中拥有权益，占于本公告日期公司已发行股本总额的28.49%。田博士表示，其对集团的整体发展前景及潜在增长充满信心。在遵守适用法律及监管规定的情况下，田博士不排除在适当时候进一步增持公司股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1268485.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"1150365699","title":"异动解读 | 宜明昂科-B盘中大跌5.17%，年度业绩亏损仍超3亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1150365699","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150365699?lang=zh_cn&edition=fundamental","pubTime":"2025-03-26 11:16","pubTimestamp":1742959004,"startTime":"0","endTime":"0","summary":"宜明昂科-B今日盘中大跌5.17%，引发市场关注。这一跌幅或与公司昨日晚间公布的2024年度业绩报告有关。根据宜明昂科发布的年度业绩公告，截至2024年12月31日，公司实现收入7414.9万元人民币，较2023年大幅增加7370万元。然而，公司仍录得3.16亿元人民币的亏损，虽较去年同期的3.79亿元有所收窄，但亏损规模依然较大。值得注意的是，宜明昂科的研发开支由2023年的2.92亿元增加至2024年的3.23亿元，增幅达10.6%。这反映了公司在新药研发方面持续加大投入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01541"],"gpt_icon":0},{"id":"1193819091","title":"异动解读 | 宜明昂科-B盘中大涨5.17%，2024年营收暴增191倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1193819091","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193819091?lang=zh_cn&edition=fundamental","pubTime":"2025-03-26 09:46","pubTimestamp":1742953593,"startTime":"0","endTime":"0","summary":"宜明昂科-B今日盘中大涨5.17%，引发市场关注。这一涨幅很可能与公司昨日发布的2024年度业绩报告密切相关。根据公告，宜明昂科-B 2024年实现营收约7414.9万元，同比大幅增长约191.1倍。值得注意的是，尽管研发支出增加，公司2024年净亏损仍同比收窄16.76%至约3.16亿元。分析人士认为，宜明昂科-B的业绩表现超出市场预期，尤其是营收的大幅增长和亏损的收窄，展现了公司业务模式的潜力和发展前景。这些积极因素可能是推动股价上涨的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01541"],"gpt_icon":0},{"id":"2522854620","title":"宜明昂科2024年业绩：收入增至7414.9万元 年内亏损降至3.17亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2522854620","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522854620?lang=zh_cn&edition=fundamental","pubTime":"2025-03-26 09:33","pubTimestamp":1742952820,"startTime":"0","endTime":"0","summary":"3月26日，宜明昂科发布年度业绩公告，截至2024年12月31日止年度，公司的收入为7414.9万元，相较于2023年，增加了7370万元，主要由于与AxionBio, Inc.达成的授权及合作协议所产生的首付款及近期付款。此外，公司的研发开支由2023年的2.92亿元增加至2024年的3.23亿元，增幅为10.6%，主要原因是临床前及CMC开支的增加以及薪资费用的上升。公司的年内亏损由2023年的3.8亿元减少至2024年的3.17亿元，显示出一定的财务改善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032609341194c0f6e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032609341194c0f6e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2522232009","title":"宜明昂科-B(01541)2024年收入大增至7414.9万元 研发开支持续加码","url":"https://stock-news.laohu8.com/highlight/detail?id=2522232009","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522232009?lang=zh_cn&edition=fundamental","pubTime":"2025-03-25 23:19","pubTimestamp":1742915973,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B 公布2024年业绩，收入约7414.9万元，同比增长约191.1倍;研发开支同比增加10.6%至3.23亿元。公司拥有人应占亏损约3.16亿元，同比收窄16.76%;每股亏损0.84元。研发开支增长主要归因于临床前及CMC开支增加4360万元;及薪金及相关福利费用因2024年临床团队不断扩大而增加740元，与公司持续推进及扩大药物管线的研发工作相符合;部分被临床试验开支及以股份为基础的付款减少1830万元所抵销。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1267631.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"宜明昂科-B(01541)2024年收入大增至7414.9万元 研发开支持续加码","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2521704954","title":"宜明昂科-B03月21日主力净流出43万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2521704954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521704954?lang=zh_cn&edition=fundamental","pubTime":"2025-03-21 16:16","pubTimestamp":1742544999,"startTime":"0","endTime":"0","summary":"03月21日, 宜明昂科-B股价跌2.69%，报收4.71元，成交金额698万元，换手率0.38%，振幅4.96%，量比0.44。宜明昂科-B今日主力资金净流出43万元，上一交易日主力净流出0万元。该股近5个交易日上涨7.80%，主力资金累计净流入47万元；近20日主力资金累计净流出806万元，其中净流出天数为11日。该股主力净额占比0.02%，港股市场排名2376/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250321170522a69eaeba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250321170522a69eaeba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2520726439","title":"宜明昂科-B03月19日主力净流入38万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2520726439","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520726439?lang=zh_cn&edition=fundamental","pubTime":"2025-03-19 16:16","pubTimestamp":1742372206,"startTime":"0","endTime":"0","summary":"03月19日, 宜明昂科-B股价涨5.69%，报收4.83元，成交金额1767万元，换手率0.95%，振幅11.16%，量比1.19。宜明昂科-B今日主力资金净流入38万元，上一交易日主力净流出52万元。该股近5个交易日下跌1.40%，主力资金累计净流出242万元；近20日主力资金累计净流出1057万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250319165824a69bc6bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250319165824a69bc6bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2520486617","title":"宜明昂科-B03月18日主力净流出52万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2520486617","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520486617?lang=zh_cn&edition=fundamental","pubTime":"2025-03-18 16:16","pubTimestamp":1742285812,"startTime":"0","endTime":"0","summary":"03月18日，宜明昂科-B股价收平报4.57元，成交金额1030万元，换手率0.59%，振幅8.97%，量比0.69。宜明昂科-B今日主力资金净流出52万元，上一交易日主力净流入103万元。该股近5个交易日下跌4.74%，主力资金累计净流出280万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出740万元，其中净流出天数为12日。该股主力净额占比0.03%，港股市场排名2504/2653。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250318165604a69a53f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250318165604a69a53f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2520537063","title":"宜明昂科-B(01541.HK)收到H股全流通备案通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2520537063","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520537063?lang=zh_cn&edition=fundamental","pubTime":"2025-03-17 09:50","pubTimestamp":1742176200,"startTime":"0","endTime":"0","summary":"宜明昂科-B(01541.HK) 公布，已收到中国证监会就实施公司H股全流通发出的备案通知书，最多可以转换未上市股份逾1,411万股为H股。公司将向联交所申请批准转换及上市。(vc/w)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-14 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230915102621607_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230915102621607_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1425048/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01541","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01541\",params:#limit:5,,,undefined,":[{"date":"2025-03-25","symbol":"01541","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"盘后","dateTimestamp":1742832000000,"actualEps":null},{"market":"HK","date":"2024-08-26","symbol":"01541","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1724601600000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-25","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01541\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01541\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1697558400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01541\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01541","date":"2025-07-16","current":-11.54941,"percent":0.570806,"low":-30.003263,"twenty":-23.682032,"median":-12.895238,"eighty":-5.965757,"high":-2.993766,"avg":-13.627081,"sd":7.891347,"marketCap":3987542334},"quantilePoints":[{"date":"2023-08-31","current":-17.746094,"twenty":-17.746094,"median":-17.746094,"eighty":-17.746094,"marketCap":6942262047},{"date":"2023-09-08","current":-19.116691,"twenty":-19.083294,"median":-18.655615,"eighty":-17.801139,"marketCap":7390149921},{"date":"2023-09-15","current":-24.765877,"twenty":-24.765877,"median":-19.116691,"eighty":-18.557812,"marketCap":9648251285},{"date":"2023-09-22","current":-25.548224,"twenty":-25.200205,"median":-24.360534,"eighty":-18.753419,"marketCap":9909519212},{"date":"2023-09-29","current":-29.804324,"twenty":-26.447668,"median":-24.870232,"eighty":-19.083294,"marketCap":11580180660},{"date":"2023-10-06","current":-24.76052,"twenty":-26.458287,"median":-24.870232,"eighty":-19.110012,"marketCap":9615852761},{"date":"2023-10-13","current":-27.113287,"twenty":-26.458287,"median":-25.206314,"eighty":-22.322253,"marketCap":10513831229},{"date":"2023-10-20","current":-26.768577,"twenty":-26.795293,"median":-25.37532,"eighty":-23.788881,"marketCap":10364168151},{"date":"2023-10-27","current":-28.665306,"twenty":-27.124745,"median":-25.753577,"eighty":-24.00727,"marketCap":11093775656},{"date":"2023-11-03","current":-26.275244,"twenty":-27.500238,"median":-26.158488,"eighty":-24.473108,"marketCap":10195797188},{"date":"2023-11-10","current":-26.039628,"twenty":-27.37617,"median":-26.041732,"eighty":-24.763734,"marketCap":10102257765},{"date":"2023-11-17","current":-26.714897,"twenty":-27.225983,"median":-26.171076,"eighty":-24.792429,"marketCap":10457707575},{"date":"2023-11-24","current":-27.539565,"twenty":-27.37617,"median":-26.271304,"eighty":-24.846191,"marketCap":10869281039},{"date":"2023-12-01","current":-28.464343,"twenty":-27.564693,"median":-26.306056,"eighty":-24.874164,"marketCap":11280854504},{"date":"2023-12-08","current":-27.67933,"twenty":-27.70336,"median":-26.447668,"eighty":-25.070837,"marketCap":10925404694},{"date":"2023-12-15","current":-27.708906,"twenty":-27.817253,"median":-26.526325,"eighty":-25.207536,"marketCap":11000236233},{"date":"2023-12-22","current":-27.916049,"twenty":-27.937914,"median":-26.714897,"eighty":-25.244891,"marketCap":11075067772},{"date":"2023-12-29","current":-28.049426,"twenty":-27.986303,"median":-26.835368,"eighty":-25.288293,"marketCap":11187315080},{"date":"2024-01-05","current":-23.146888,"twenty":-27.970711,"median":-26.68937,"eighty":-25.200205,"marketCap":9166863527},{"date":"2024-01-12","current":-26.439512,"twenty":-27.935571,"median":-26.500765,"eighty":-25.200205,"marketCap":10476415460},{"date":"2024-01-19","current":-25.435754,"twenty":-27.916049,"median":-26.490281,"eighty":-25.212424,"marketCap":10064841995},{"date":"2024-01-26","current":-23.636611,"twenty":-27.83997,"median":-26.442842,"eighty":-24.972615,"marketCap":9316526605},{"date":"2024-02-02","current":-21.195554,"twenty":-27.817533,"median":-26.372788,"eighty":-24.783518,"marketCap":8343716598},{"date":"2024-02-09","current":-18.727145,"twenty":-27.802108,"median":-26.275244,"eighty":-24.041989,"marketCap":7408322361},{"date":"2024-02-16","current":-17.739662,"twenty":-27.801452,"median":-26.252628,"eighty":-23.794995,"marketCap":7019198358},{"date":"2024-02-23","current":-22.387155,"twenty":-27.764049,"median":-26.165159,"eighty":-23.13759,"marketCap":8811413717},{"date":"2024-03-01","current":-17.708555,"twenty":-27.735275,"median":-26.04068,"eighty":-22.460898,"marketCap":6974299434},{"date":"2024-03-08","current":-19.229551,"twenty":-27.718352,"median":-26.025076,"eighty":-21.141323,"marketCap":7576693323},{"date":"2024-03-15","current":-16.157629,"twenty":-27.69116,"median":-25.695795,"eighty":-19.998834,"marketCap":6360680815},{"date":"2024-03-22","current":-15.411367,"twenty":-27.66021,"median":-25.548224,"eighty":-19.057216,"marketCap":6061354659},{"date":"2024-03-28","current":-14.696214,"twenty":-27.629432,"median":-25.408294,"eighty":-18.737655,"marketCap":6038905197},{"date":"2024-04-05","current":-13.011166,"twenty":-27.602384,"median":-25.364375,"eighty":-18.557812,"marketCap":5342971884},{"date":"2024-04-12","current":-13.094845,"twenty":-27.539565,"median":-25.225009,"eighty":-18.239836,"marketCap":5380387654},{"date":"2024-04-19","current":-13.014894,"twenty":-27.51439,"median":-25.154554,"eighty":-17.708555,"marketCap":5342971884},{"date":"2024-04-26","current":-13.779237,"twenty":-27.443648,"median":-24.972615,"eighty":-16.602696,"marketCap":5649781194},{"date":"2024-05-03","current":-12.839078,"twenty":-27.434442,"median":-24.870232,"eighty":-16.184677,"marketCap":5260657191},{"date":"2024-05-10","current":-13.282389,"twenty":-27.357513,"median":-24.774698,"eighty":-14.702373,"marketCap":5455219193},{"date":"2024-05-17","current":-13.228926,"twenty":-27.225983,"median":-24.581805,"eighty":-14.243189,"marketCap":5425286577},{"date":"2024-05-24","current":-13.350651,"twenty":-27.145452,"median":-23.955191,"eighty":-13.966896,"marketCap":5462702347},{"date":"2024-05-31","current":-13.410156,"twenty":-27.124745,"median":-23.750163,"eighty":-13.747349,"marketCap":5492634962},{"date":"2024-06-07","current":-14.158514,"twenty":-27.039336,"median":-23.288627,"eighty":-13.645876,"marketCap":5791961118},{"date":"2024-06-14","current":-13.347574,"twenty":-26.971042,"median":-23.123643,"eighty":-13.527845,"marketCap":5455219193},{"date":"2024-06-21","current":-13.283836,"twenty":-26.926395,"median":-22.448608,"eighty":-13.452996,"marketCap":5417803423},{"date":"2024-06-28","current":-12.683619,"twenty":-26.848726,"median":-21.974147,"eighty":-13.40419,"marketCap":5170859344},{"date":"2024-07-05","current":-11.291057,"twenty":-26.759122,"median":-21.059976,"eighty":-13.359292,"marketCap":4602139648},{"date":"2024-07-12","current":-12.246119,"twenty":-26.720023,"median":-20.206581,"eighty":-13.323498,"marketCap":4998746805},{"date":"2024-07-19","current":-11.915911,"twenty":-26.704686,"median":-19.229551,"eighty":-13.282563,"marketCap":4864050035},{"date":"2024-07-26","current":-11.780484,"twenty":-26.652155,"median":-19.050696,"eighty":-13.224977,"marketCap":4826634265},{"date":"2024-08-02","current":-13.633124,"twenty":-26.594701,"median":-18.753419,"eighty":-13.20236,"marketCap":5582432809},{"date":"2024-08-09","current":-9.567144,"twenty":-26.54166,"median":-18.630761,"eighty":-13.102374,"marketCap":3943622105},{"date":"2024-08-16","current":-8.483685,"twenty":-26.496571,"median":-18.451463,"eighty":-13.086665,"marketCap":3498374448},{"date":"2024-08-23","current":-8.095604,"twenty":-26.47337,"median":-18.020488,"eighty":-13.035717,"marketCap":3352452947},{"date":"2024-08-30","current":-7.377309,"twenty":-26.446703,"median":-17.739662,"eighty":-12.990136,"marketCap":3034418906},{"date":"2024-09-06","current":-4.227864,"twenty":-26.442176,"median":-17.681919,"eighty":-12.840212,"marketCap":1739833281},{"date":"2024-09-13","current":-4.503325,"twenty":-26.43833,"median":-16.602696,"eighty":-12.741292,"marketCap":1848339013},{"date":"2024-09-20","current":-4.539912,"twenty":-26.433601,"median":-16.202037,"eighty":-12.246119,"marketCap":1874530051},{"date":"2024-09-27","current":-5.476578,"twenty":-26.311976,"median":-15.844451,"eighty":-11.915911,"marketCap":2274878785},{"date":"2024-10-04","current":-6.596451,"twenty":-26.302504,"median":-15.05764,"eighty":-11.832338,"marketCap":2727609596},{"date":"2024-10-10","current":-5.983695,"twenty":-26.285201,"median":-14.496802,"eighty":-11.807116,"marketCap":2458216056},{"date":"2024-10-18","current":-5.191078,"twenty":-26.27288,"median":-14.209972,"eighty":-11.719903,"marketCap":2121474130},{"date":"2024-10-25","current":-7.104995,"twenty":-26.248892,"median":-14.119017,"eighty":-11.287262,"marketCap":2903463713},{"date":"2024-11-01","current":-6.615271,"twenty":-26.199776,"median":-13.881638,"eighty":-9.764235,"marketCap":2705160134},{"date":"2024-11-08","current":-6.847628,"twenty":-26.169892,"median":-13.803075,"eighty":-8.441853,"marketCap":2787474827},{"date":"2024-11-15","current":-7.078843,"twenty":-26.118271,"median":-13.690467,"eighty":-8.248986,"marketCap":2851081635},{"date":"2024-11-22","current":-6.784782,"twenty":-26.059844,"median":-13.633178,"eighty":-7.853303,"marketCap":2731351173},{"date":"2024-11-29","current":-5.682581,"twenty":-26.04047,"median":-13.539989,"eighty":-7.45767,"marketCap":2286103516},{"date":"2024-12-06","current":-5.602773,"twenty":-26.037499,"median":-13.514674,"eighty":-7.358253,"marketCap":2248687746},{"date":"2024-12-13","current":-6.121403,"twenty":-26.029477,"median":-13.45004,"eighty":-7.218028,"marketCap":2451992323},{"date":"2024-12-20","current":-5.137492,"twenty":-25.962318,"median":-13.411134,"eighty":-7.087735,"marketCap":2048757705},{"date":"2024-12-27","current":-4.957491,"twenty":-25.887099,"median":-13.400213,"eighty":-7.078006,"marketCap":1975442320},{"date":"2025-01-03","current":-5.238569,"twenty":-25.753577,"median":-13.368079,"eighty":-6.925822,"marketCap":2089488475},{"date":"2025-01-10","current":-5.002231,"twenty":-25.638014,"median":-13.3526,"eighty":-6.765934,"marketCap":1987661551},{"date":"2025-01-17","current":-5.018682,"twenty":-25.5579,"median":-13.317479,"eighty":-6.665777,"marketCap":1995807705},{"date":"2025-01-24","current":-5.323319,"twenty":-25.548224,"median":-13.283546,"eighty":-6.596451,"marketCap":2130219244},{"date":"2025-01-28","current":-5.224689,"twenty":-25.503236,"median":-13.282823,"eighty":-6.532117,"marketCap":2101707706},{"date":"2025-02-07","current":-5.549725,"twenty":-25.42477,"median":-13.246663,"eighty":-6.254752,"marketCap":2219826937},{"date":"2025-02-14","current":-5.930475,"twenty":-25.395104,"median":-13.220128,"eighty":-6.076947,"marketCap":2366457707},{"date":"2025-02-21","current":-6.375256,"twenty":-25.366564,"median":-13.201126,"eighty":-6.054191,"marketCap":2557892324},{"date":"2025-02-28","current":-5.632443,"twenty":-25.318672,"median":-13.116805,"eighty":-5.974648,"marketCap":2252411553},{"date":"2025-03-07","current":-5.782376,"twenty":-25.249925,"median":-13.099044,"eighty":-5.827424,"marketCap":2321653861},{"date":"2025-03-14","current":-4.421401,"twenty":-25.219975,"median":-13.087912,"eighty":-5.725677,"marketCap":1775861550},{"date":"2025-03-21","current":-4.778207,"twenty":-25.207536,"median":-13.071662,"eighty":-5.66584,"marketCap":1918419243},{"date":"2025-03-28","current":-6.735516,"twenty":-25.163684,"median":-13.026305,"eighty":-5.651503,"marketCap":2276850015},{"date":"2025-04-03","current":-7.956153,"twenty":-25.0977,"median":-13.01303,"eighty":-5.66026,"marketCap":2684157710},{"date":"2025-04-11","current":-6.344288,"twenty":-25.036833,"median":-12.972072,"eighty":-5.68428,"marketCap":2126146167},{"date":"2025-04-17","current":-6.122985,"twenty":-24.972615,"median":-12.844749,"eighty":-5.691075,"marketCap":2056903859},{"date":"2025-04-25","current":-8.576896,"twenty":-24.895951,"median":-12.836736,"eighty":-5.703559,"marketCap":2883738480},{"date":"2025-05-02","current":-7.700417,"twenty":-24.872853,"median":-12.82514,"eighty":-5.710649,"marketCap":2594550017},{"date":"2025-05-09","current":-7.730765,"twenty":-24.846191,"median":-12.683619,"eighty":-5.725677,"marketCap":2623061555},{"date":"2025-05-16","current":-8.311097,"twenty":-24.799485,"median":-12.12195,"eighty":-5.751942,"marketCap":2843007711},{"date":"2025-05-23","current":-11.289802,"twenty":-24.776462,"median":-11.940532,"eighty":-5.771038,"marketCap":3873496179},{"date":"2025-05-30","current":-15.223569,"twenty":-24.763734,"median":-11.970101,"eighty":-5.797425,"marketCap":5246123111},{"date":"2025-06-06","current":-16.623143,"twenty":-24.617548,"median":-12.331836,"eighty":-5.827424,"marketCap":5743038499},{"date":"2025-06-13","current":-15.603079,"twenty":-24.258649,"median":-12.701975,"eighty":-5.862056,"marketCap":5392753881},{"date":"2025-06-20","current":-14.878015,"twenty":-24.00727,"median":-12.82804,"eighty":-5.90109,"marketCap":5132076957},{"date":"2025-06-27","current":-13.023121,"twenty":-23.933348,"median":-12.837907,"eighty":-5.91626,"marketCap":4504823106},{"date":"2025-07-04","current":-14.906416,"twenty":-23.89321,"median":-12.895238,"eighty":-5.935244,"marketCap":5156515418},{"date":"2025-07-11","current":-12.022018,"twenty":-23.818294,"median":-12.972072,"eighty":-5.957179,"marketCap":4154538489},{"date":"2025-07-16","current":-11.54941,"twenty":-23.682032,"median":-12.895238,"eighty":-5.965757,"marketCap":3987542334}],"updateTime":1752762923028}}}